New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Pieris Pharmaceuticals, Inc.
PIRS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

22M

Biotechnology

Next Earning date - 12 Nov 2024

22M

Biotechnology

Next Earning date - 12 Nov 2024

16.92USD
Shape0.31 ( 1.86%)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-98%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

27%

Quote Panel

Shape
Updated October 18, 2024
1W 3.26 % 1M -1.12 % 3M 131.72 % 1Y -19.23 %

Key Metrics

Shape
  • Market Cap

    22.34M


  • Shares Outstanding

    1.32M


  • Share in Float

    1.32M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    16.919


  • Average Volume

    125693


  • Beta

    0.669


  • Range

    6.2-23.2


  • Industry

    Biotechnology


  • Website

    https://www.pieris.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.07x

P/S Ratio

1.18x

P/B Ratio

0.0

Debt/Equity

-114.1%

Net Margin

$-19.2

EPS

How PIRS compares to sector?

P/E Ratio

Relative Strength

Shape

PIRS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$7M

ShapeNaN%

2025-Revenue

$0.29

Shape89%

2025-EPS

$5M

Shape-30%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-10.40
vs -19.20

Q4.22

arrow
arrow

N/A

-8.80
vs -10.40

Q1.23

arrow
arrow

N/A

-14.40
vs -5.60

Q2.23

arrow
arrow

+136%

4
vs -11.20

Q3.23

arrow
arrow

N/A

-8.80
vs -10.40

Q4.23

arrow
arrow

N/A

-4.00
vs -8.80

Q1.24

arrow
arrow

N/A

-3.95
vs -14.40

Q2.24

arrow
arrow

N/A

-2.76
vs 4

Q3.24

arrow
arrow

N/A

-4.00
vs -8.80

Q4.24

arrow
arrow

N/A

-4.80
vs -4.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+32%

5.4M  vs 4.1M

Q4.22

arrow
arrow

-31%

5.8M  vs 8.4M

Q1.23

arrow
arrow

-82%

1.9M  vs 11M

Q2.23

arrow
arrow

+442%

20.1M  vs 3.7M

Q3.23

arrow
arrow

+264%

19.5M  vs 5.4M

Q4.23

arrow
arrow

-78%

1.3M  vs 5.8M

Q1.24

arrow
arrow

-97%

53K  vs 1.9M

Q2.24

arrow
arrow

-100%

NA  vs 20.1M

Q3.24

arrow
arrow

-95%

1.1M  vs 19.5M

Q4.24

arrow
arrow

-18%

1.1M  vs 1.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-24%

-0.24
vs -0.23

Q4.22

arrow
arrow

-29%

-0.29
vs -0.24

Q1.23

arrow
arrow

-80%

-0.80
vs -0.29

Q2.23

arrow
arrow

+10%

0.1
vs -0.80

Q3.23

arrow
arrow

-35%

-0.35
vs 0.1

Q4.23

arrow
arrow

-17%

-0.17
vs -0.35

Q1.24

arrow
arrow

-22%

-0.22
vs -0.17

Q2.24

arrow
arrow

-19%

-0.19
vs -0.22

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

68

68
vs 76

-11%

Q3.22

arrow
arrow

63

63
vs 68

-7%

Q4.22

arrow
arrow

64

64
vs 63

2%

Q1.23

arrow
arrow

62

62
vs 64

-3%

Q2.23

arrow
arrow

48

48
vs 62

-23%

Q3.23

arrow
arrow

44

44
vs 48

-8%

Q4.23

arrow
arrow

46

46
vs 44

5%

Q1.24

arrow
arrow

40

40
vs 46

-13%

Earnings Growth

Latest News